[1]
Stankiewicz, M. 2023. Apalutamide as a therapeutic option in case of local failure in the nmCRPC. OncoReview. 13, 1(49) (Apr. 2023), 13-19. DOI:https://doi.org/10.24292/01.OR.131010423.